Search engine for discovering works of Art, research articles, and books related to Art and Culture
Javascript must be enabled to continue!
The Trial of Epaminondas
View through CrossRef
The story of Epaminondas' trial has come down to us in two divergent traditions, which differ as to the occasion, the ground, and the result of the action. One group of authors, of whom Plutarch may be taken as the chief representative, gives the following data:(1) The trial took place after Epaminondas' first campaign in Peloponnesus— i.e. in spring 369 b.c.(2) The charge preferred against Epaminondas was that he had outstayed his term of office as boeotarch.(3) The trial resulted in his acquittal.
Title: The Trial of Epaminondas
Description:
The story of Epaminondas' trial has come down to us in two divergent traditions, which differ as to the occasion, the ground, and the result of the action.
One group of authors, of whom Plutarch may be taken as the chief representative, gives the following data:(1) The trial took place after Epaminondas' first campaign in Peloponnesus— i.
e.
in spring 369 b.
c.
(2) The charge preferred against Epaminondas was that he had outstayed his term of office as boeotarch.
(3) The trial resulted in his acquittal.
Related Results
International Breast Cancer Study Group (IBCSG)
International Breast Cancer Study Group (IBCSG)
This section provides current contact details and a summary of recent or ongoing clinical trials being coordinated by International Breast Cancer Study Group (IBCSG). Clinical tria...
UM ESTUDO DE CASO SOBRE NOVOS BRADOS DO EPAMINONDAS AMERICANO
UM ESTUDO DE CASO SOBRE NOVOS BRADOS DO EPAMINONDAS AMERICANO
Analisa as cráticas apresentadas por Manoel Paixão dos Santos Zacheo, o Epaminondas Americano, á utilidade da agricultura para o Império do Brasil, ao conflito fundiário envolven...
Epaminondas at Leuctra, 371 b.c.
Epaminondas at Leuctra, 371 b.c.
Abstract
This chapter addresses the time of Theban general Epaminondas at Leuctra, specifically reviewing his battle in Leuctra. Leuctra in 371 BC was established as...
Continuity of care: Perspectives of participants, investigators, and healthcare providers after trial completion in South Africa
Continuity of care: Perspectives of participants, investigators, and healthcare providers after trial completion in South Africa
Abstract
Background
Despite decades of updates to frameworks and guidelines for the conduct of clinical trials, what happens to participants when a trial ends rem...
Behavioural Optimisation To Address Trial Conduct Challenges: Case Study In The UK-REBOA Trial
Behavioural Optimisation To Address Trial Conduct Challenges: Case Study In The UK-REBOA Trial
Abstract
Background: Clinical trials comprise multiple processes at various stages of the trial lifecycle. These processes often involve complex behaviours such as recruiti...
Abstract 6455: Investigating clinical trial eligibility criteria to improve MatchMiner trial matching
Abstract 6455: Investigating clinical trial eligibility criteria to improve MatchMiner trial matching
Abstract
As the number of precision medicine (PM) trials and the volume of patient genomic data have grown, it has become challenging for clinicians and trial staff ...
Abstract 4091: Design and adoption of MatchMiner at Dana-Farber Cancer Institute
Abstract 4091: Design and adoption of MatchMiner at Dana-Farber Cancer Institute
Abstract
Precision medicine (PM) drugs targeting alterations such as EGFR mutations and BCR-ABL fusions have provided great clinical benefit to patients. However, wi...
Abstract P160: MatchMiner: An open-source platform for cancer precision medicine
Abstract P160: MatchMiner: An open-source platform for cancer precision medicine
Abstract
With the advent of next generation sequencing in cancer care, patients’ tumors can be genomically profiled and specific genetic alterations can be targeted ...